Vor Biopharma, Inc. VOR 深 沪
等待开盘 04-01 09:30:00 美东时间
17.66
+2.960
+20.14%
华盛通- 最 高17.74
- 今 开15.04
- 成交量 200.43万股
- 最 低 14.8601
- 昨 收 14.70
- 总市值 7.33亿
- 52周最高 65.80
- 市盈率 静 --
- 换手率 4.83%
- 52周最低 2.622
- 委 比 99.34%
- 总股本 4151.98万
- 历史最高 1272.40
- 量 比 2.05
- 振 幅 19.59%
- 历史最低 2.622
- 每 手 1
- 风险率 13.60%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 潜在涨幅172.14%！Alumis获Oppenheimer上调目标价至55美元；摩根大通首予希捷科技"超配"评级，目标价525美元
今日重点评级关注：Oppenheimer：维持Alumis"跑赢大市"评级，目标价从50美元升至55美元；美银证券：维持Rocket Pharmaceuticals"买入"评级，目标价从8美元升至9美元
03-31 16:30
Vor Biopharma Q4 Adj. EPS $(1.63) Beats $(1.64) Estimate
Vor Biopharma (NASDAQ:VOR) reported quarterly losses of $(1.63) per share which beat the analyst consensus estimate of $(1.64) by 0.61 percent. This is a 81.48 percent increase over losses of $(8.80) per share from the
03-30 21:29
U.S. RESEARCH ROUNDUP- Ferguson Enterprises, Hartford Insurance Group, JP Morgan
U.S. RESEARCH ROUNDUP- Ferguson Enterprises, Hartford Insurance Group, JP Morgan March 30 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Ferguson Enterprises, Hartford Insurance Group and JP Morgan, on Monday. HIGHLIGHT
03-30 15:35
What's Behind The Jump In Vor Biopharma Stock?
Shares of Vor Biopharma Inc. (NASDAQ: VOR) are trading higher Friday after pricing a $14.05 private placement of 5.4 million shares.
03-27 23:15
BUZZ-U.S. STOCKS ON THE MOVE-Alphabet, Phathom, Argan
BUZZ-U.S. STOCKS ON THE MOVE-Alphabet, Phathom, Argan Workspace search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 March 27 (Reuters) - Wall Street's main indexes were on track to open lower
03-27 21:15
Vor Biopharma shares are trading higher after the company announced the pricing of its private placement of 5.4 million shares at $14.05 per share.
Vor Biopharma shares are trading higher after the company announced the pricing...
03-27 20:26
Vor Bio announces $75M private placement
Vor Bio (VOR) said on Friday it had entered a securities purchase agreement to sell 5.34M shares at $14.05 each in a private placement, for gross proceeds of about $75M. The private placement is expec...
03-27 20:20
Vor Bio Commences ~$75M Offering Of 5.338M Common Shares At $14.05/Share
Vor Bio (Nasdaq: VOR), a clinical-stage biotechnology company transforming the treatment of autoimmune diseases, announced today that it has entered into a securities purchase agreement to sell 5,338,078 shares of its
03-27 20:06
Vor Bio sells 5,338,078 shares in private placement; gross proceeds rise to $75 million
Vor Bio sells 5,338,078 shares in private placement; gross proceeds rise to $75 million Vor Bio entered a securities purchase agreement to sell 5,338,078 shares of common stock in a private placement at USD 14.05 per share. Gross proceeds are expected to be about USD 75.0 million. The financing was
03-27 20:02
BRIEF-Vor Bio Announces $75 Million Private Placement With Tcgx
BRIEF-Vor Bio Announces $75 Million Private Placement With Tcgx Vor Biopharma Inc VOR.O : VOR BIO ANNOUNCES $75 MILLION PRIVATE PLACEMENT WITH TCGX VOR BIOPHARMA INC - BIO TO USE PROCEEDS TO ADVANCE TELITACICEPT CLINICAL DEVELOPMENT Source text: ID:nGNX6J6sGd Further company coverage: VOR.O
03-27 20:01
